Intratracheal Budesonide and Bronchopulmonary Dysplasia in Extremely Preterm Infants
To the Editor Dr Manley and colleagues reported that endotracheal administration of budesonide did not affect the incidence of bronchopulmonary dysplasia (BPD) in extremely preterm infants.1 We believe 2 issues may influence the interpretation of these findings.
Authors
- Guisheng Xian
- Yan Wang (ORCID: https://orcid.org/0000-0003-2563-255X)
- Zhiwei Long (ORCID: https://orcid.org/0009-0008-0917-5903)
Institutions
- First Affiliated Hospital of Guangzhou Medical University (CN)
- Guangzhou Medical University (CN)
Publication Details
- Journal
- JAMA
- Published
- 2025-05-08
- DOI
- https://doi.org/10.1001/jama.2025.2874
- Primary Topic
- Neonatal Respiratory Health Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00